The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarction (Q42851023)

8 November 2017

title

The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarction (English)

1 reference

8 November 2017

1 reference

myocardial infarction

1 reference

5

1 reference

8 November 2017

9

Robert M Califf

1 reference

8 November 2017

3

Lars Køber

1 reference

8 November 2017

8

John J V McMurray

1 reference

8 November 2017

7

Mark C Petrie

1 reference

8 November 2017

10

Marc A Pfeffer

1 reference

8 November 2017

2

Hajime Uno

1 reference

8 November 2017

1

Amil M Shah

1 reference

8 November 2017

Eric J Velazquez

4

1 reference

8 November 2017

Michael R MacDonald

series ordinal

6

1 reference

8 November 2017

Scott D Solomon

series ordinal

11

1 reference

8 November 2017

publication date

1 November 2010

1 reference

European Journal of Heart Failure

8 November 2017

published in

1 reference

8 November 2017

volume

12

1 reference

8 November 2017

issue

11

1 reference

8 November 2017

page(s)

1229-1237

1 reference

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

8 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ179

Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ179

Effect of diabetes mellitus and insulin use on survival after acute myocardial infarction in the elderly (the Cooperative Cardiovascular Project)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ179

Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ179

Late-onset heart failure after myocardial infarction: trends in incidence and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ179

Ventricular remodeling does not accompany the development of heart failure in diabetic patients after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ179

Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ179

Predictors of late development of heart failure in stable survivors of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ179

Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ179

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ179

Valsartan in acute myocardial infarction trial (VALIANT): rationale and design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ179

Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ179

The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction: the VALIANT Echo Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ179

Acute heart failure in patients with acute myocardial infarction treated with primary percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ179

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ179

Relationship between myocardial perfusion and dysfunction in diabetic cardiomyopathy: a study of quantitative contrast echocardiography and strain rate imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ179

Diastolic dysfunction and diabetic cardiomyopathy: evaluation by Doppler echocardiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ179

Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ179

Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ179

Impaired Inotropic Response in Type 2 Diabetes Mellitus: A Strain Rate Imaging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ179

Three-dimensional assessment of left ventricular systolic strain in patients with type 2 diabetes mellitus, diastolic dysfunction, and normal ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ179

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFQ179

1 reference

8 November 2017

1 reference